Information de reference pour ce titreAccession Number: | 00043426-202208000-00008.
|
Author: | McDaniel, Charles Griffin BS *; Commander, Sarah J. MD +; DeLaura, Isabel BA ++; Cantrell, Sarah MLIS ++,[S]; Leraas, Harold J. MD +; Moore, Carrie B. MD, PhD +; Reed, Christopher R. MD +; Pahl, Kristy S. MD [//],[P]; Tracy, Elisabeth T. MD +,#
|
Institution: | (*)Department of Surgery, Duke University (+)Department of Surgery ([//])Division of Pediatric Hematology-Oncology ([P])Department of Pediatrics (#)Division of Pediatric Surgery, Duke University Medical Center (++)Duke University School of Medicine ([S])Duke University Medical Center Library and Archives, Durham, NC
|
Title: | |
Source: | Journal of Pediatric Hematology/Oncology. 44(6):323-335, August 2022.
|
Abstract: | Given the limited information on the coagulation abnormalities of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in pediatric patients, we designed a systematic review to evaluate this topic. A comprehensive literature search was conducted for "SARS-CoV-2," "coagulopathy," and "pediatrics." Two authors independently screened the articles that the search returned for bleeding, thrombosis, anticoagulant and/or antiplatelet usage, and abnormal laboratory markers in pediatric patients with SARS-CoV-2, and the authors then extracted the relevant data. One hundred twenty-six publications were included. Thirty-four (27%) studies reported thrombotic complications in 504 patients. Thirty-one (25%) studies reported bleeding complications in 410 patients. Ninety-eight (78%) studies reported abnormal laboratory values in 6580 patients. Finally, 56 (44%) studies reported anticoagulant and/or antiplatelet usage in 3124 patients. The variety of laboratory abnormalities and coagulation complications associated with SARS-CoV-2 presented in this review highlights the complexity and variability of the disease presentation in infants and children.
Copyright (C) 2022 Wolters Kluwer Health, Inc. All rights reserved.
|
Author Keywords: | coagulopathy; bleeding; thrombosis; pediatrics.
|
References: | 1. Dong E, Du H, Gardner L. An interactive web-based dashboard to track COVID-19 in real time. Lancet Infect Dis. 2020;20:533-534.
2. Shekerdemian LS, Mahmood NR, Wolfe KK, et al. Characteristics and outcomes of children with coronavirus disease 2019 (COVID-19) infection admitted to US and Canadian pediatric intensive care units. JAMA Pediatr. 2020;174:868-873.
3. Vinayagam S, Sattu K. SARS-CoV-2 and coagulation disorders in different organs. Life Sci. 2020;260:118431.
4. Matricardi PM, Dal Negro RW, Nisini R. The first, holistic immunological model of COVID-19: implications for prevention, diagnosis, and public health measures. Pediatr Allergy Immunol. 2020;31:454-470.
5. Gomez-Mesa JE, Galindo-Coral S, Montes MC, et al. Thrombosis and coagulopathy in COVID-19. Curr Probl Cardiol. 2021;46:100742.
6. Tang N, Li D, Wang X, et al. Abnormal coagulation parameters are associated with poor prognosis in patients with novel coronavirus pneumonia. J Thromb Haemost. 2020;18:844-847.
7. Wool GD, Miller JL. The impact of COVID-19 Disease on platelets and coagulation. Pathobiology. 2020;88:15-27.
8. Asakura H, Ogawa H. Overcoming bleeding events related to extracorporeal membrane oxygenation in COVID-19. Lancet Respir Med. 2020;8:e87-e88.
9. Al-Samkari H, Karp Leaf RS, Dzik WH, et al. COVID-19 and coagulation: bleeding and thrombotic manifestations of SARS-CoV-2 infection. Blood. 2020;136:489-500.
10. Fraisse M, Logre E, Pajot O, et al. Thrombotic and hemorrhagic events in critically ill COVID-19 patients: a French monocenter retrospective study. Crit Care. 2020;24:275.
11. Iba T, Levy JH, Levi M, et al. Coagulopathy of coronavirus disease 2019. Crit Care Med. 2020;48:1358-1364.
12. Danzi GB, Loffi M, Galeazzi G, et al. Acute pulmonary embolism and COVID-19 pneumonia: a random association? Eur Heart J. 2020;41:1858.
13. Ranucci M, Ballotta A, Di Dedda U, et al. The procoagulant pattern of patients with COVID-19 acute respiratory distress syndrome. J Thromb Haemost. 2020;18:1747-1751.
14. Panigada M, Bottino N, Tagliabue P, et al. Hypercoagulability of COVID-19 patients in intensive care unit: a report of thromboelastography findings and other parameters of hemostasis. J Thromb Haemost. 2020;18:1738-1742.
15. Zhang Y, Cao W, Xiao M, et al. Clinical and coagulation characteristics of 7 patients with critical COVID-2019 pneumonia and acro-ischemia. Zhonghua Xue Ye Xue Za Zhi. 2020;41:E006.
16. Sinaei R, Pezeshki S, Parvaresh S, et al. Why COVID-19 is less frequent and severe in children: a narrative review. World J Pediatr. 2020;17:10-20.
17. Dayal D. We urgently need guidelines for managing COVID-19 in children with comorbidities. Acta Paediatr. 2020;109:1497-1498.
18. Sarzaeim M, Rezaei N. Kawasaki disease and multisystem inflammatory syndrome in children with COVID-19. SN Compr Clin Med. 2020. [Epub ahead of print].
19. Achey MA, Nag UP, Robinson VL, et al. The developing balance of thrombosis and hemorrhage in pediatric surgery: clinical implications of age-related changes in hemostasis. Clin Appl Thromb Hemost. 2020;26:1076029620929092.
20. Appel IM, Grimminck B, Geerts J, et al. Age dependency of coagulation parameters during childhood and puberty. J Thromb Haemost. 2012;10:2254-2263.
21. Lippi G, Franchini M, Montagnana M, et al. Coagulation testing in pediatric patients: the young are not just miniature adults. Semin Thromb Hemost. 2007;33:816-820.
22. Miller BE, Bailey JM, Mancuso TJ, et al. Functional maturity of the coagulation system in children: an evaluation using thrombelastography. Anesth Analg. 1997;84:745-748.
23. Ludvigsson JF. Systematic review of COVID-19 in children shows milder cases and a better prognosis than adults. Acta Paediatr. 2020;109:1088-1095.
24. McGowan J, Sampson M, Salzwedel DM, et al. PRESS Peer Review of Electronic Search Strategies: 2015 guideline statement. J Clin Epidemiol. 2016;75:40-46.
25. Abrams JY, Godfred-Cato SE, Oster ME, et al. Multisystem inflammatory syndrome in children associated with severe acute respiratory syndrome coronavirus 2: a systematic review. J Pediatr. 2020;226:45-54.e1.
26. Ahmed M, Advani S, Moreira A, et al. Multisystem inflammatory syndrome in children: a systematic review. EClinicalMedicine. 2020. [Epub ahead of print].
27. Al-Ghafry M, Aygun B, Appiah-Kubi A, et al. Are children with SARS-CoV-2 infection at high risk for thrombosis? Viscoelastic testing and coagulation profiles in a case series of pediatric patients. Pediatr Blood Cancer. 2020. [Epub ahead of print].
28. Alilio PM, Ebeling-Koning NE, Roth KR, et al. Lung point-of-care (POCUS) ultrasound in a pediatric COVID-19 case. Radiol Case Rep. 2020;15:2314-2318.
29. Alsayegh F, Mousa SA. Challenges in the management of sickle cell disease during SARS-CoV-2 pandemic. Clin Appl Thromb Hemost. 2020;26:1076029620955240.
30. Alvarez Roman MT, Butta Coll N, Garcia Barcenilla S, et al. Registry of patients with congenital bleeding disorders and COVID-19 in Madrid. Haemophilia. 2020;26:773-778.
31. Andina D, Colmenero I, Santonja C, et al. Suspected COVID-19-related reticulated purpura of the soles in an infant. Pediatr Dermatol. 2020;38:301-303.
32. Andina D, Noguera-Morel L, Bascuas-Arribas M, et al. Chilblains in children in the setting of COVID-19 pandemic. Pediatr Dermatol. 2020;37:406-411.
33. Appavu B, Deng D, Dowling MM, et al. Arteritis and large vessel occlusive strokes in children following COVID-19 infection. Pediatrics. 2020. [Epub ahead of print].
34. Aronoff SC, Hall A, Del Vecchio MT. The natural history of SARS-Cov-2 related multisystem inflammatory syndrome in children (MIS-C): a systematic review. J Pediatric Infect Dis Soc. 2020;9:746-751.
35. Asif R, Marcella Sinead OM. Rare complication of COVID-19 presenting as isolated headache. BMJ Case Rep. 2020. [Epub ahead of print].
36. Basalely A, Brathwaite K, Duong D, et al. COVID-19 in children with kidney disease: a report of 2 cases. Kidney Med. 2020;3:120-123.
37. Belhadjer Z, Meot M, Bajolle F, et al. Acute heart failure in multisystem inflammatory syndrome in children in the context of global SARS-CoV-2 pandemic. Circulation. 2020;142:429-436.
38. Beslow LA, Linds AB, Fox CK, et al. Pediatric ischemic stroke: an infrequent complication of SARS-CoV-2. Ann Neurol. 2020;89:657-665.
39. Bhattacharjee S, Banerjee M. Immune thrombocytopenia secondary to COVID-19: a systematic review. SN Compr Clin Med. 2020. [Epub ahead of print].
40. Bhumbra S, Malin S, Kirkpatrick L, et al. Clinical features of critical coronavirus disease 2019 in children. Pediatr Crit Care Med. 2020;21:e948-e953.
41. Bigdelian H, Sedighi M, Sabri MR, et al. Right atrial thrombus in a COVID-19 child treated through cardiac surgery. Front Cardiovasc Med. 2020;7:579522.
42. Cabrero-Hernandez M, Garcia-Salido A, Leoz-Gordillo I, et al. Severe SARS-CoV-2 infection in children with suspected acute abdomen: a case series from a tertiary hospital in Spain. Pediatr Infect Dis J. 2020;39:e195-e198.
43. Cai X, Ma Y, Li S, et al. Clinical characteristics of 5 COVID-19 cases with non-respiratory symptoms as the first manifestation in children. Front Pediatr. 2020;8:258.
44. Calo Carducci FI, De Ioris MA, Agrati C, et al. Hyperinflammation in two severe acute respiratory syndrome coronavirus 2-infected adolescents successfully treated with the interleukin-1 inhibitor anakinra and glucocorticoids. Front Pediatr. 2020;8:576912.
45. Cantor A, Miller J, Zachariah P, et al. Acute hepatitis is a prominent presentation of the multisystem inflammatory syndrome in children: a single-center report. Hepatology. 2020;72:1522-1527.
46. Caro-Paton GL, de Azagra-Garde AM, Garcia-Salido A, et al. Shock and myocardial injury in children with multisystem inflammatory syndrome associated with SARS-CoV-2 infection: what we know. Case series and review of the literature. J Intensive Care Med. 2020;36:392-403.
47. Christophers B, Gallo Marin B, Oliva R, et al. Trends in clinical presentation of children with COVID-19: a systematic review of individual participant data. Pediatr Res. 2020. [Epub ahead of print].
48. Ciuca C, Fabi M, Di Luca D, et al. Myocarditis and coronary aneurysms in a child with acute respiratory syndrome coronavirus 2. ESC Heart Fail. 2020;8:761-765.
49. Corwin DJ, Sartori LF, Chiotos K, et al. Distinguishing multisystem inflammatory syndrome in children from Kawasaki disease and benign inflammatory illnesses in the SARS-CoV-2 pandemic. Pediatr Emerg Care. 2020;36:554-558.
50. Davies P, Evans C, Kanthimathinathan HK, et al. Intensive care admissions of children with paediatric inflammatory multisystem syndrome temporally associated with SARS-CoV-2 (PIMS-TS) in the UK: a multicentre observational study. Lancet Child Adolesc Health. 2020;4:669-677.
51. de Farias ECF, Justino MCA, et al. Multisystem inflammatory syndrome in a child associated with coronavirus disease 19 in the Brazilian Amazon: fatal outcome in an infant. Rev Paul Pediatr. 2020. [Epub ahead of print].
52. Del Borrello G, Giraudo I, Bondone C, et al. SARS-COV-2-associated coagulopathy and thromboembolism prophylaxis in children: a single-center observational study. J Thromb Haemost. 2020;19:522-530.
53. Dhanalakshmi K, Venkataraman A, Balasubramanian S, et al. Epidemiological and clinical profile of pediatric inflammatory multisystem syndrome-temporally associated with SARS-CoV-2 (PIMS-TS) in Indian children. Indian Pediatr. 2020;57:1010-1014.
54. Diorio C, Henrickson SE, Vella LA, et al. Multisystem inflammatory syndrome in children and COVID-19 are distinct presentations of SARS-CoV-2. J Clin Invest. 2020;130:5967-5975.
55. Diorio C, McNerney KO, Lambert M, et al. Evidence of thrombotic microangiopathy in children with SARS-CoV-2 across the spectrum of clinical presentations. Blood Adv. 2020;4:6051-6063.
56. Du H, Dong X, Zhang JJ, et al. Clinical characteristics of 182 pediatric COVID-19 patients with different severities and allergic status. Allergy. 2020;76:510-532.
57. Dufort EM, Koumans EH, Chow EJ, et al. Multisystem inflammatory syndrome in children in New York State. N Engl J Med. 2020;383:347-358.
58. Eghbali A, Shokrollahi S, Mahdavi NS, et al. COVID-19 in pediatric patients: a case series. J Cell Mol Anesth. 2020;5:3-5.
59. El Hachem M, Diociaiuti A, Concato C, et al. A clinical, histopathological and laboratory study of 19 consecutive Italian paediatric patients with Chilblain-like lesions: lights and shadows on the relationship with COVID-19 infection. J Eur Acad Dermatol Venereol. 2020;34:2620-2629.
60. Essajee F, Solomons R, Goussard P, et al. Child with tuberculous meningitis and COVID-19 coinfection complicated by extensive cerebral sinus venous thrombosis. BMJ Case Rep. 2020. [Epub ahead of print].
61. Faqeeh S, Madkhali R. Acute reversible renal failure requiring temporary dialysis in a patient with COVID-19. Radiol Case Rep. 2020;15:2449-2452.
62. Feld L, Belfer J, Kabra R, et al. A case series of the 2019 novel coronavirus (SARS-CoV-2) in 3 febrile infants in New York. Pediatrics. 2020. [Epub ahead of print].
63. Felsenstein S, Willis E, Lythgoe H, et al. Presentation, treatment response and short-term outcomes in paediatric multisystem inflammatory syndrome temporally associated with SARS-CoV-2 (PIMS-TS). J Clin Med. 2020;9:1-21.
64. Fisler G, Haimed A, Levy CF, et al. Severe coronavirus disease 2019 infection in an adolescent patient after hematopoietic stem cell transplantation. Chest. 2020;158:e139-e142.
65. Flood SM, Osborne CM, Martin B, et al. Severe SARS-CoV-2 infection in a pediatric patient requiring extracorporeal membrane oxygenation. Case Rep Pediatr. 2020;2020:8885022.
66. Garcia-Howard M, Herranz-Aguirre M, Moreno-Galarraga L, et al. Case Report: benign infantile seizures temporally associated with COVID-19. Front Pediatr. 2020;8:507.
67. Garcia-Salido A, Leoz-Gordillo I, Martinez de Azagra-Garde A, et al. Children in critical care due to severe acute respiratory syndrome coronavirus 2 infection: experience in a Spanish hospital. Pediatr Crit Care Med. 2020;21:e576-e580.
68. Gonzalez-Dambrauskas S, Vasquez-Hoyos P, Camporesi A, et al. Pediatric critical care and COVID-19. Pediatrics. 2020. [Epub ahead of print].
69. Gulko E, Overby P, Ali S, et al. Vessel wall enhancement and focal cerebral arteriopathy in a pediatric patient with acute infarct and COVID-19 infection. AJNR: Am J Neuroradiol. 2020;41:2348-2350.
70. Gupta ML, Gothwal S, Gupta RK, et al. Duration of viral clearance in children with SARS-CoV-2 infection in Rajasthan, India. Indian Pediatr. 2020;58:123-125.
71. Gutierrez Amezcua JM, Jain R, Kleinman G, et al. COVID-19-induced neurovascular injury: a case series with emphasis on pathophysiological mechanisms. SN Compr Clin Med. 2020;2:2109-2125.
72. Heidemann SM, Tilford B, Bauerfeld C, et al. Three cases of pediatric multisystem inflammatory syndrome associated with COVID-19 due to SARS-CoV-2. Am J Case Rep. 2020. [Epub ahead of print].
73. Hoang A, Chorath K, Moreira A, et al. COVID-19 in 7780 pediatric patients: a systematic review. EClinicalMedicine. 2020;24:100433.
74. Hosseninasab A, Bafti MS, Ebrahimi S, et al. Coronavirus disease 2019 in children with acute respiratory infection: A study from southeastern Iran. Shiraz E Med J. 2020;21:1-7.
75. Hussain Z, Wangmo R, Gonbo S. Deep vein thrombosis after trivial blunt trauma at high altitude in a SARS-CoV-2 positive child: complication of the hypercoagulable state. Indian Pediatr. 2020;57:1182-1183.
76. Jacobi M, Lancrei HM, Brosh-Nissimov T, et al. Purpurona: a novel report of COVID-19-related Henoch-Schonlein purpura in a child. Pediatr Infect Dis J. 2020;40:93-94.
77. Jiang L, Tang K, Levin M, et al. COVID-19 and multisystem inflammatory syndrome in children and adolescents. Lancet Infect Dis. 2020;20:e276-e288.
78. Kamali Aghdam M, Bakhtiari H, Diaz DN, et al. Neurological manifestations of novel coronavirus disease in a 2-month-old infant: a case report. J Pediatr Neurol. 2020;19:210-212.
79. Kaushik A, Gupta S, Sood M, et al. A systematic review of multisystem inflammatory syndrome in children associated with SARS-CoV-2 infection. Pediatr Infect Dis J. 2020;39:e340-e346.
80. Kaushik S, Aydin SI, Derespina KR, et al. Multisystem inflammatory syndrome in children associated with severe acute respiratory syndrome coronavirus 2 infection (MIS-C): a multi-institutional study from New York City. J Pediatr. 2020;224:24-29.
81. Kaya G, Kaya A, Saurat JH. Clinical and histopathological features and potential pathological mechanisms of skin lesions in COVID-19: review of the literature. Dermatopathology (Basel). 2020;7:3-16.
82. Kazi MA, Ghosh S, Roychowdhury S, et al. A case study of dual infection of dengue and COVID-19: presenting as multiorgan dysfunction in an infant. J Trop Pediatr. 2020. [Epub ahead of print].
83. Khalili M, Iranmanesh B, Mohammadi S, et al. Cutaneous and histopathological features of coronavirus disease 2019 in pediatrics: a review article. Dermatol Ther. 2020;34:e14554.
84. Kharoud HK, Asim R, Siegel L, et al. Review of clinical characteristics and laboratory findings of COVID-19 in children-systematic review and meta-analysis. medRxiv. 2020. [Epub ahead of print].
85. Kim H, Shim JY, Ko JH, et al. Multisystem inflammatory syndrome in children related to COVID-19: the first case in Korea. J Korean Med Sci. 2020;35:e391.
86. Kirenga B, Muttamba W, Kayongo A, et al. Characteristics and outcomes of admitted patients infected with SARS-CoV-2 in Uganda. BMJ Open Respir Res. 2020. [Epub ahead of print].
87. Korkmaz MF, Ture E, Dorum BA, et al. The epidemiological and clinical characteristics of 81 children with COVID-19 in a pandemic hospital in Turkey: an observational cohort study. J Korean Med Sci. 2020. [Epub ahead of print].
88. Kotula JJ, Balakumar N, Khan D, et al. Bilateral pulmonary emboli in a teenager with positive SARS-CoV-2 antibody. Pediatr Pulmonol. 2020;56:271-273.
89. Kremer S, Lersy F, de Seze J, et al. Brain MRI findings in severe COVID-19: a retrospective observational study. Radiology. 2020;297:E242-E251.
90. Kulkarni R, Rajput U, Dawre R, et al. Severe malnutrition and anemia are associated with severe COVID in infants. J Trop Pediatr. 2020. [Epub ahead of print].
91. Lang P, Eichholz T, Bakchoul T, et al. Defibrotide for the treatment of PIMS-TS in two pediatric patients. J Pediatric Infect Dis Soc. 2020;9:622-625.
92. Latimer G, Corriveau C, DeBiasi RL, et al. Cardiac dysfunction and thrombocytopenia-associated multiple organ failure inflammation phenotype in a severe paediatric case of COVID-19. Lancet Child Adolesc Health. 2020;4:552-554.
93. Lee M, Hilado M, Sotelo S, et al. Acute kidney injury in multisystem inflammatory syndrome in children (MIS-C): a case report. SN Compr Clin Med. 2020;2:2899-2902.
94. Lee PY, Day-Lewis M, Henderson LA, et al. Distinct clinical and immunological features of SARS-COV-2-induced multisystem inflammatory syndrome in children. J Clin Invest. 2020;130:5942-5950.
95. Licciardi F, Pruccoli G, Denina M, et al. SARS-CoV-2-induced Kawasaki-like hyperinflammatory syndrome: a novel COVID phenotype in children. Pediatrics. 2020. [Epub ahead of print].
96. Lima-Setta F, Magalhaes-Barbosa MC, Rodrigues-Santos G, et al. Multisystem inflammatory syndrome in children (MIS-C) during SARS-CoV-2 pandemic in Brazil: a multicenter, prospective cohort study. J Pediatr. 2020;97:354-361.
97. Lindan CE, Mankad K, Ram D, et al. Neuroimaging manifestations in children with SARS-CoV-2 infection: a multinational, multicentre collaborative study. Lancet Child Adolesc Health. 2020;5:167-177.
98. Ma H, Hu J, Tian J, et al. A single-center, retrospective study of COVID-19 features in children: a descriptive investigation. BMC Med. 2020;18:123.
99. Ma X, Liu S, Chen L, et al. The clinical characteristics of pediatric inpatients with SARS-CoV-2 infection: a meta-analysis and systematic review. J Med Virol. 2020;93:234-240.
100. Mahmoudi S, Mehdizadeh M, Badv RS, et al. The coronavirus disease 2019 (COVID-19) in children: a study in an Iranian children's referral hospital. Infect Drug Resist. 2020;13:2649-2655.
101. Makiello P, Svirpliene S, Finlay L, et al. Paediatric inflammatory multisystem syndrome temporally associated with COVID-19: a new virus and a new case presentation. BMJ Case Rep. 2020. [Epub ahead of print].
102. Mamishi S, Movahedi Z, Mohammadi M, et al. Multisystem inflammatory syndrome associated with SARS-CoV-2 infection in 45 children: a first report from Iran. Epidemiol Infect. 2020;148:e196.
103. Mehl SC, Whitlock RS, Marcano DC, et al. Necrotizing enterocolitis-like pneumatosis intestinalis in an infant with COVID-19. Pediatr Infect Dis J. 2020;40:85-86.
104. Minen F, Hands C, Mustafa MR, et al. Thrombophilia in pediatric patients with multisystem inflammatory syndrome in children secondary to coronavirus disease 2019 supported on extracorporeal membrane oxygenation. ASAIO J. 2021;67:7-11.
105. Morrone KA, Strumph K, Liszewski MJ, et al. Acute chest syndrome in the setting of SARS-COV-2 infections-a case series at an urban medical center in the Bronx. Pediatr Blood Cancer. 2020. [Epub ahead of print].
106. Ng KF, Bandi S, Bird PW, et al. COVID-19 in neonates and infants: progression and recovery. Pediatr Infect Dis J. 2020;39:e140-e142.
107. Oba J, Silva CA, Toma RK, et al. COVID-19 and coinfection with Clostridioides (Clostridium) difficile in an infant with gastrointestinal manifestation. Einstein (Sao Paulo). 2020;18:eRC6048.
108. Onal P, Kilinc AA, Aygun F, et al. COVID-19 IN Turkey: a tertiary center experience. Pediatr Int. 2020;63:797-805.
109. Panda PK, Sharawat IK, Panda P, et al. Neurological complications of SARS-CoV-2 infection in children: a systematic review and meta-analysis. J Trop Pediatr. 2020. [Epub ahead of print].
110. Patel PA, Chandrakasan S, Mickells GE, et al. Severe pediatric COVID-19 presenting with respiratory failure and severe thrombocytopenia. Pediatrics. 2020. [Epub ahead of print].
111. Pereira MFB, Litvinov N, Farhat SCL, et al. Severe clinical spectrum with high mortality in pediatric patients with COVID-19 and multisystem inflammatory syndrome. Clinics (Sao Paulo). 2020;75:e2209.
112. Qiu H, Wu J, Hong L, et al. Clinical and epidemiological features of 36 children with coronavirus disease 2019 (COVID-19) in Zhejiang, China: an observational cohort study. Lancet Infect Dis. 2020;20:689-696.
113. Regev T, Antebi M, Eytan D, et al. Pediatric inflammatory multisystem syndrome with central nervous system involvement and hypocomplementemia following SARS-COV-2 infection. Pediatr Infect Dis J. 2020;39:E206-E207.
114. Rekhtman S, Tannenbaum R, Strunk A, et al. Mucocutaneous disease and related clinical characteristics in hospitalized children and adolescents with COVID-19 and multisystem inflammatory syndrome in children. J Am Acad Dermatol. 2020;84:408-414.
115. Rodriguez-Gonzalez M, Castellano-Martinez A, Cascales-Poyatos HM, et al. Cardiovascular impact of COVID-19 with a focus on children: a systematic review. World J Clin Cases. 2020;8:5250-5283.
116. Rodriguez-Portilla RE, Munaico-Abanto ME, Paredes-Zevallos RP, et al. Cardiac tamponade and intracerebral hemorrhage in a child with COVID-19: case report. Rev Fac Med Hum. 2020;20:743-747.
117. Saad MA, Alfishawy M, Nassar M, et al. Covid-19 and autoimmune diseases: a systematic review of reported cases. Curr Rheumatol Rev. 2020;17:193-204.
118. Sabatino J, Ferrero P, Chessa M, et al. COVID-19 and congenital heart disease: results from a Nationwide Survey. J Clin Med. 2020;9:1774.
119. Saeed A, Shorafa E. Status epilepticus as a first presentation of COVID-19 infection in a 3 years old boy; case report and review the literature. IDCases. 2020;22:e00942.
120. Saha S, Ahmed ANU, Sarkar PK, et al. The direct and indirect impact of SARS-CoV-2 infections on neonates: a series of 26 cases in Bangladesh. Pediatr Infect Dis J. 2020;39:398-405.
121. Savic D, Alsheikh TM, Alhaj AK, et al. Ruptured cerebral pseudoaneurysm in an adolescent as an early onset of COVID-19 infection: case report. Acta Neurochir (Wien). 2020;162:2725-2729.
122. Schneider CW, Penney SW, Helfrich AM, et al. A novel use of romiplostim for SARS-CoV-2-induced thrombocytopenia. J Pediatr Hematol Oncol. 2020;43:788-790.
123. Shahbaznejad L, Navaeifar MR, Abbaskhanian A, et al. Clinical characteristics of 10 children with a pediatric inflammatory multisystem syndrome associated with COVID-19 in Iran. BMC Pediatr. 2020;20:513.
124. Simon Junior H, Sakano TMS, Rodrigues RM, et al. Multisystem inflammatory syndrome associated with COVID-19 from the pediatric emergency physician's point of view. J Pediatr. 2020;97:140-159.
125. Soares A, Loggetto SR, Manga FCM, et al. Outcome of SARS-CoV-2 and immune thrombocytopenia in a pediatric patient. Hematol Transfus Cell Ther. 2020;43:101-103.
126. Soysal A, Gonullu E, Arslan H, et al. Comparison of clinical and laboratory features and treatment options of 237 comparison of clinical and laboratory features and treatment options of 237 symptomatic and asymptomatic children infected with SARS-CoV-2 in the early phase of the COVID-19 pandemic in Turkey. Jpn J Infect Dis. 2020;74:273-279.
127. Storch-de-Gracia P, Leoz-Gordillo I, Andina D, et al. Clinical spectrum and risk factors for complicated disease course in children admitted with SARS-CoV-2 infection. An Pediatr (Engl Ed). 2020;93:323-333.
128. Sun D, Chen X, Li H, et al. SARS-CoV-2 infection in infants under 1 year of age in Wuhan City, China. W J Pediatr. 2020;16:260-266.
129. Sweeney N, Merrick B, Pickering S, et al. Clinical utility of targeted SARS-CoV-2 serology testing to aid the diagnosis and management of suspected missed, late or post-COVID-19 infection syndromes: results from a pilot service. medRxiv. 2020;16:e0249791.
130. Theocharis P, Wong J, Pushparajah K, et al. Multimodality cardiac evaluation in children and young adults with multisystem inflammation associated with COVID-19. Eur Heart J Cardiovasc Imaging. 2020;22:896-903.
131. Tian Y, Rong L, Nian W, et al. Review article: gastrointestinal features in COVID-19 and the possibility of faecal transmission. Aliment Pharmacol Ther. 2020;51:843-851.
132. Tiwari L, Shekhar S, Bansal A, et al. COVID-19 associated arterial ischaemic stroke and multisystem inflammatory syndrome in children: a case report. Lancet Child Adolesc Health. 2021;5:88-90.
133. Torres JP, Izquierdo G, Acuna M, et al. Multisystem inflammatory syndrome in children (MIS-C): report of the clinical and epidemiological characteristics of cases in Santiago de Chile during the SARS-CoV-2 pandemic. Int J Infect Dis. 2020;100:75-81.
134. Trogen B, Gonzalez FJ, Shust GF. COVID-19-associated myocarditis in an adolescent. Pediatr Infect Dis J. 2020;39:E204-E205.
135. Tsao HS, Chason HM, Fearon DM. Immune thrombocytopenia (ITP) in a pediatric patient positive for SARS-CoV-2. Pediatrics. 2020;146:e20201419.
136. Turbin RE, Wawrzusin PJ, Sakla NM, et al. Orbital cellulitis, sinusitis and intracranial abnormalities in two adolescents with COVID-19. Orbit. 2020;39:305-310.
137. Udrea DS, Lopez M, Avesar M, et al. Acute COVID-19 infection in a pediatric patient with ROHHAD. J Pediatr Genet. 2020. [Epub ahead of print].
138. Vilela TS, Braga JAP, Loggetto SR. Hemoglobinopathy and pediatrics in the time of COVID-19. Hematol Transfus Cell Ther. 2020;43:87-100.
139. Visveswaran GK, Morparia K, Narang S, et al. Severe acute respiratory syndrome coronavirus 2 infection and thrombosis: phlegmasia cerulea dolens presenting with venous gangrene in a child. J Pediatr. 2020;226:281.e1-284.e1.
140. Walinjkar JA, Makhija SC, Sharma HR, et al. Central retinal vein occlusion with COVID-19 infection as the presumptive etiology. Indian J Ophthalmol. 2020;68:2572-2574.
141. Williams V, Dash N, Suthar R, et al. Clinico-laboratory profile, intensive care needs, treatment details, and outcome of pediatric inflammatory multisystem syndrome temporally associated with SARS-CoV-2 (PIMS-TS): a systematic review and meta-analysis. medRxiv. 2020. [Epub ahead of print].
142. Xiong X, Chua GT, Chi S, et al. A comparison between Chinese children infected with coronavirus disease-2019 and with severe acute respiratory syndrome 2003. J Pediatr. 2020;224:30-36.
143. Xu H, Liu E, Xie J, et al. A follow-up study of children infected with SARS-CoV-2 from Western China. medRxiv. 2020;8:623.
144. Yamamoto L, Dos Santos EH, Pinto LS, et al. SARS-CoV-2 infections with emphasis on pediatric patients: a narrative review. Rev Inst Med Trop Sao Paulo. 2020;62:1-12.
145. Yang Y, Zheng H, Peng L, et al. Viral shedding and immunological features of children COVID-19 patients. medRxiv. 2020. [Epub ahead of print].
146. Yasuhara J, Kuno T, Takagi H, et al. Clinical characteristics of COVID-19 in children: a systematic review. Pediatr Pulmonol. 2020;55:2565-2575.
147. Zachariah P, Johnson CL, Halabi KC, et al. Epidemiology, clinical features, and disease severity in patients with coronavirus disease 2019 (COVID-19) in a Children's Hospital in New York City, New York. JAMA Pediatr. 2020;174:e202430.
148. Zimmermann P, Curtis N. COVID-19 in children, pregnancy and neonates: a review of epidemiologic and clinical features. Pediatr Infect Dis J. 2020;39:469-477.
149. Adams GL, Manson RJ, Turner I, et al. The balance of thrombosis and hemorrhage in surgery. Hematol Oncol Clin North Am. 2007;21:13-24.
150. Robinson V, Achey MA, Nag UP, et al. Thrombosis in infants in the neonatal intensive care unit: analysis of a large national database. J Thromb Haemost. 2021;19:400-407.
151. Tsankov BK, Allaire JM, Irvine MA, et al. Severe COVID-19 infection and pediatric comorbidities: a systematic review and meta-analysis. Int J Infect Dis. 2021;103:246-256.
152. Andrew M, Paes B, Milner R, et al. Development of the human coagulation system in the full-term infant. Blood. 1987;70:165-172.
153. Jung HL. Venous thromboembolism in children and adolescents. Blood Res. 2016;51:149-151.
154. Avila J, Long B, Holladay D, et al. Thrombotic complications of COVID-19. Am J Emerg Med. 2021;39:213-218.
155. Hanff TC, Mohareb AM, Giri J, et al. Thrombosis in COVID-19. Am J Hematol. 2020;95:1578-1589.
156. Batlle D, Wysocki J, Soler MJ, et al. Angiotensin-converting enzyme 2: enhancing the degradation of angiotensin II as a potential therapy for diabetic nephropathy. Kidney Int. 2012;81:520-528.
157. Asakura H, Ogawa H. COVID-19-associated coagulopathy and disseminated intravascular coagulation. Int J Hematol. 2021;113:45-57.
158. Wollina U, Karadag AS, Rowland-Payne C, et al. Cutaneous signs in COVID-19 patients: a review. Dermatol Ther. 2020;33:e13549.
159. Koschitzky M, Oyola RR, Lee-Wong M, et al. Pediatric COVID toes and fingers. Clin Dermatol. 2021;39:84-91.
160. Pourbagheri-Sigaroodi A, Bashash D, Fateh F, et al. Laboratory findings in COVID-19 diagnosis and prognosis. Clin Chim Acta. 2020;510:475-482.
161. Osawa I, Okamoto K, Ikeda M, et al. Dynamic changes in fibrinogen and D-dimer levels in COVID-19 patients on nafamostat mesylate. J Thromb Thrombolysis. 2020;51:649-656.
162. Xu P, Zhou Q, Xu J. Mechanism of thrombocytopenia in COVID-19 patients. Ann Hematol. 2020;99:1205-1208.
163. Zheng SY, Xiao QY, Xie XH, et al. Association between secondary thrombocytosis and viral respiratory tract infections in children. Sci Rep. 2016;6:22964.
164. Rose SR, Petersen NJ, Gardner TJ, et al. Etiology of thrombocytosis in a general medicine population: analysis of 801 cases with emphasis on infectious causes. J Clin Med Res. 2012;4:415-423.
165. Tang N, Bai H, Chen X, et al. Anticoagulant treatment is associated with decreased mortality in severe coronavirus disease 2019 patients with coagulopathy. J Thromb Haemost. 2020;18:1094-1099.
166. Loi M, Branchford B, Kim J, et al. COVID-19 anticoagulation recommendations in children. Pediatr Blood Cancer. 2020;67:e28485.
167. Kollias A, Kyriakoulis KG, Dimakakos E, et al. Thromboembolic risk and anticoagulant therapy in COVID-19 patients: emerging evidence and call for action. Br J Haematol. 2020;189:846-847.
168. Godino C, Scotti A, Maugeri N, et al. Antithrombotic therapy in patients with COVID-19?-rationale and evidence. Int J Cardiol. 2021;324:261-266.
169. Ho G, Dusendang JR, Schmittdiel J, et al. Association of chronic anticoagulant and antiplatelet use on disease severity in SARS-COV-2 infected patients. J Thromb Thrombolysis. 2021;52:476-481.
170. Musoke N, Lo KB, Albano J, et al. Anticoagulation and bleeding risk in patients with COVID-19. Thromb Res. 2020;196:227-230.
171. Rentsch CT, Beckman JA, Tomlinson L, et al. Early initiation of prophylactic anticoagulation for prevention of coronavirus disease 2019 mortality in patients admitted to hospital in the United States: cohort study. BMJ. 2021;372:n311.
|
Language: | English.
|
Document Type: | Original Articles.
|
Journal Subset: | Nursing. Clinical Medicine. Health Professions.
|
ISSN: | 1077-4114
|
NLM Journal Code: | 9505928, b57
|
DOI Number: | https://dx.doi.org/10.1097/MPH.0...- ouverture dans une nouvelle fenêtre
|
Annotation(s) | |
|
|